Request Demo
Last update 20 Mar 2025
AUR-106
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism PDL1 inhibitors(Programmed death-ligand 1 inhibitors), TIGIT inhibitors(T cell immunoglobulin and ITIM domains inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with AUR-106NCT05861947
A Phase I, Open Label, Dose-Escalation, First in Human (FIH) Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of AUR106 in Patients With Select Relapsed Advanced Malignancies (JIVAN)
CTRI/2023/04/052088
A Phase I, Open Label, Dose-Escalation, First in Human (FIH) study evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of AUR106 in patients with select relapsed advanced malignancies (JIVAN) - JIVAN
100 Clinical Results associated with AUR-106
Login to view more data
100 Translational Medicine associated with AUR-106
Login to view more data
100 Patents (Medical) associated with AUR-106
Login to view more data
100 Deals associated with AUR-106
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced cancer | Phase 1 | India | 26 Aug 2023 | |
| Colonic Cancer | Phase 1 | India | 26 Aug 2023 | |
| Esophageal Carcinoma | Phase 1 | India | 26 Aug 2023 | |
| Kidney Neoplasms | Phase 1 | India | 26 Aug 2023 | |
| Non-Small Cell Lung Cancer | Phase 1 | India | 26 Aug 2023 | |
| Stomach Cancer | Phase 1 | India | 26 Aug 2023 | |
| Urothelial Carcinoma of the Urinary Bladder | Phase 1 | India | 26 Aug 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free